Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer

High-grade Bladder Cancer (BLCA) represents the most aggressive and treatment-resistant cancer that renders the patients with poor survival. However, only a few biomarkers have been identified for the detection and treatment of BLCA. Recent studies show that ganglioside GD2 can be used as cancer bio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Vantaku, Venkatrao, Donepudi, Sri Ramya, Ambati, Chandrashekar R., Jin, Feng, Putluri, Vasanta, Nguyen, Khoa, Rajapakshe, Kimal, Coarfa, Cristian, Battula, Venkata Lokesh, Lotan, Yair, Putluri, Nagireddy
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5707048/
https://ncbi.nlm.nih.gov/pubmed/29221154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21038
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados